Invest1 distinct publisher3 min readPublished
PitchBook counts a third of US private-equity portfolio companies held five years or more, and about $860bn of net asset value stuck in funds past seven. The delay is the cost.
The Investor · Invest desk
Compiled by The InvestorSomething wrong?How this is made
Divide PitchBook's $860 billion of aged net asset value by the roughly 4,566 companies implied by a 33.8% share of 13,509, and you get about $188 million apiece [1][3]. The two figures do not share a denominator: the company count covers all US PE-backed companies held five years or more, while the $860 billion is scoped to funds more than seven years old [4][5]. Read the per-company figure as an order of magnitude for how large these assets are, not as a mark. Against the industry's $3.8 trillion, the aged pile is roughly 23% [1][2].
That is the part that matters to anyone waiting on a wire. An unexited company is a deferred distribution, and PitchBook's Kyle Walters concedes the mechanism directly: capital that should have been returned to investors is instead sitting in the seven-to-ten-year age bucket in unusual volume, with no apparent route to a successful exit [6]. GPs decide when that changes, because the timing is theirs unless their hand is forced, which Walters says history suggests it usually is not [11]. So the adjustment arrives as delay rather than as marks.
The entry math explains why waiting does not fix it. Walters describes assets bought at 12 times and now worth perhaps 10 [9], a 17% gap on the multiple alone [4], on companies acquired at 2020-2021 peaks with capital that cost close to nothing, before rates reached their highest in 40 years and financial engineering stopped working [7][8]. Cheap debt was the trade [7], which means the equity absorbs the gap first, and the equity is the LP's money.
Then look at the exits actually on offer. Walters expects platform owners to buy aged assets, on the explicit logic that the strong take advantage of the weak, and in his telling the buyer's opening line is that it knows this is a zombie company [13]. That is a genuine exit and a discounted one. The alternative he allows is simply that these companies cannot sit in a portfolio forever [14].
Which is why "not yet systemic" is the wrong test to apply here. Walters says a structural crisis needs another layer of risk stacked on top of the existing one before breaking points appear [10], and he is probably right about breakage. The liquidity squeeze does not wait for breakage. It shows up in LP cash flow as absence, and it also blocks the repair, since a portfolio that looks like this is a hard thing to raise a new fund against [12]. Fortune's own attempt at an endpoint came from asking Gemini what finishes off a zombie horde, which produced decomposition and a note about Reddit consensus [15]. That is the current state of the forward view: one analyst's expectation of platform buyers, and a chatbot.
Ranked by verification strength, evidence, and original report placement.
Fortune says this means north of 4,500 PE-backed companies are in some zombie stage right now.
Walters describes companies bought at 12x that are maybe worth 10x, bought at the 2020-2021 valuation peak.
Walters says GPs have the advantage of timing to a large degree unless their hand is forced, which historically is not the case with private markets.
Fortune asked Gemini for the natural endpoint of a zombie crisis and printed the answer, which described total biological collapse and decomposition and said most users on Reddit agree biological decay is the ultimate limiting factor.
The private equity industry is described as $3.8 trillion in size.
There are 13,509 companies backed by U.S. PE firms.
Follow any of these and your For You feed starts watching them — no settings page required.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Single-outlet vendor data, named analyst, unreconciled scopes
The core numbers are specific and attributed to a recognised data provider (PitchBook) with an on-the-record analyst, which is better than anonymous market colour. But there is exactly one publisher in the cluster, no link to or excerpt from the underlying dataset, no methodology for what makes a holding a 'zombie' beyond an age threshold, and the two headline statistics are drawn from different populations (companies held five-plus years versus funds older than seven years). Illustrative figures like 12x-to-10x are analyst shorthand, and the piece mixes sourced data with a chatbot passage that cites Reddit consensus, which lowers the evidentiary tone of the item as a whole.
No adoption-type signals in scope
The supplied material contains no releases, deployments, benchmarks, pricing or licence changes, security incidents, or disclosed usage figures. It reports a market-structure statistic and analyst commentary, so there is nothing to measure on an adoption axis without inventing transaction or behaviour data the source does not provide.
Apocalypse framing above the analyst's own caveats
The presentation runs ahead of the substance. Headline framing borrows zombie-horror and Walking Dead imagery and attaches an $860bn number to a population defined mainly by holding age, while the article's own expert says this is not systemic failure, that a structural crisis would need another layer of risk, and that GPs retain timing control. The underlying facts — long holds, delayed distributions, multiple compression — are real and material, which keeps the gap moderate rather than severe, but the scope mismatch between the count and the NAV, plus the Gemini-and-Reddit digression, tilt the item toward overstatement.
Vendor dataset promotion inside an engagement-driven newsletter
Both parties have visible interests. The figures and the framing come from PitchBook, a commercial data vendor whose analyst benefits from its proprietary dataset being the reference point for a widely discussed market problem, and the article is built almost entirely on that one vendor's numbers. Fortune's Term Sheet is a subscription newsletter whose reach rewards vivid framing, which shows in the zombie metaphor and the chatbot bit. No sponsor, LP, or competing data provider is quoted to push back, and no disclosure of dataset construction is offered.
Directionally credible, weakly corroborated
Confidence in the direction of travel is reasonable: long hold periods, a thin exit market and multiple compression after the ZIRP-era buyout boom are internally consistent and attributed to a named analyst at a recognised data provider. Confidence in the precise magnitudes is lower, because there is one publisher, one vendor, no methodology, no independent dataset, and the headline figures cover different populations. The forward-looking part — resolution through platform add-ons versus wind-downs — is an unquantified expectation.
invest
PE's $860bn zombie shelf sits in funds past seven years, and the GP still holds the clock1 distinct publisher
invest
The SEC just put a number on the pre-IPO grey market: 46% average markup, $74M, 800 buyers1 distinct publisher
product
Canva's $7.1bn markdown is an inference bill, not a mood swing1 distinct publisher
invest
Harvard's $2.2 billion SpaceX position is half its disclosed US equity book1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 26, 2026